Department of Pediatrics, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, China.
Department of Pediatrics, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
J Investig Med. 2023 Dec;71(8):854-864. doi: 10.1177/10815589231186534. Epub 2023 Aug 24.
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is extremely rare in children. Renal involvement is a common and severe complication of AAV as it can cause end stage kidney disease (ESKD). ANCA renal risk score (ARRS) is helpful in predicting long-term ESKD in patients with ANCA-associated glomerulonephritis (AAGN). This retrospective study included 61 consecutive patients with kidney biopsy specimen-proven AAGN from Clinical Center for Children's Kidney Disease in China. Each patient was assessed by eGFR, normal glomeruli, and tubular atrophy/interstitial fibrosis, and the renal outcome was evaluated using the ARRS. Based on the ARRS, 27 (44.26%), 21 (34.43%), and 13 (21.31%) patients were divided into the low-risk, medium-risk, and high-risk groups, respectively. The median follow-up period was 46.36 (14.58-95.62) months. The high-risk group had worse renal outcomes than the low-risk group (p< 0.05) and the medium-risk group (p < 0.05). COX multivariate regression analysis showed that eGFR ≤ 15 ml/min/1.73 m (p = 0.015, Hazard Ratio (HR) = 9.574, 95% CI 4.205-25.187) and ARRS (p = 0.012, HR = 2.115, 95% CI 1.206-4.174) were independent risk factors for ESKD.The area under the curve for ESKD prediction of ARRS was 0.880, and the best cutoff value was 5.50. Delong test result showed that ARRS exhibited better predictive value for ESKD than the Berden classification (p < 0.001) and rapidly progressive glomerulonephritis (p < 0.001). This is the first study to investigate the value of the ARRS for predicting renal prognosis among Chinese children. The ARRS is a preferred index that can predict ESKD in Chinese children with AAGN.
抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)在儿童中极为罕见。肾脏受累是 AAV 的常见且严重的并发症,因为它可导致终末期肾病(ESKD)。ANCA 肾风险评分(ARRS)有助于预测 ANCA 相关性肾小球肾炎(AAGN)患者的长期 ESKD。这项回顾性研究纳入了来自中国儿童肾脏病临床中心的 61 例经肾活检证实的 AAGN 连续患者。每位患者均通过估算肾小球滤过率(eGFR)、正常肾小球和肾小管萎缩/间质纤维化进行评估,并使用 ARRS 评估肾脏结局。根据 ARRS,27(44.26%)、21(34.43%)和 13(21.31%)例患者分别分为低危、中危和高危组。中位随访时间为 46.36(14.58-95.62)个月。高危组的肾脏结局比低危组(p<0.05)和中危组(p<0.05)差。COX 多变量回归分析显示,eGFR≤15ml/min/1.73m(p=0.015,危险比(HR)=9.574,95%CI 4.205-25.187)和 ARRS(p=0.012,HR=2.115,95%CI 1.206-4.174)是 ESKD 的独立危险因素。ARRS 预测 ESKD 的曲线下面积为 0.880,最佳截断值为 5.50。Delong 检验结果显示,ARRS 对 ESKD 的预测价值优于 Berden 分类(p<0.001)和急进性肾小球肾炎(p<0.001)。这是第一项研究 ARRS 在中国儿童 AAGN 中预测肾脏预后的价值。ARRS 是预测中国儿童 AAGN 患者 ESKD 的首选指标。